AgingResearch.NewsJoin free

Norges Teknisk-Naturvitenskapelige Universitet

CompanyNorwayFounded 1996

RORWikidata

Norges Teknisk-Naturvitenskapelige Universitet develops one asset, in phase 2 (ExPlas in Alzheimer's disease). Mostly plasma or blood product; based in Norway, founded in 1996.

1
Asset
Furthest stage
Phase 2
42
Trials
1
Signal

Pipeline

1

  • ExPlas

    Transfers plasma from young, exercise-trained donors to deliver potentially beneficial circulating factors.

    Phase 2, Plasma or blood product, Alzheimer's disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials54
  • Signals1
  • Similar companies6

Papers

Intelligence